key: cord-1046576-419ifefo
authors: de Melo, Caroline Vilas Boas; Bhuiyan, Maruf Ahmed; Gatua, Winfred Nyoroka; Kanyerezi, Stephen; Uzairue, Leonard; Abechi, Priscilla; Kumar, Karan; Rahmat, Jabale; Giwa, Abdulazeez; Mwandira, Gracious; Olamilekan, Abisogun Mujib; George, Tiffany Ezinne; Adejinmi, Oluwapelumi John; Ibironke, Monsurat Ademidun; Rotimi, Olayemi David; Abo-Elenein, Dina Aly Mahmoud Aly; Abubakar, Ridwanullah Abiodun; Usman, Mahmood; Adewunmi, Ifeoluwa; Akinpelu, Oyewumi; Emmanuel, Olajide; Reang, Khatendra; Olalekan, Akadiri; Carl, Sarah H.
title: Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cells
date: 2020-09-09
journal: bioRxiv
DOI: 10.1101/2020.09.09.289850
sha: 692bc1114bc9640524b4ac4f59621a153d91c82c
doc_id: 1046576
cord_uid: 419ifefo

Introduction Over 24 million people have been infected globally with the novel coronavirus, SARS-CoV-2, with more than 820,000 succumbing to the resulting COVID-19 disease as of the end of August 2020. The molecular mechanisms underlying the pathogenesis of the disease are not completely elucidated. Thus, we aim to understand host response to SARS-CoV-2 infection by comparing samples collected from two distinct compartments (infection site and blood), obtained from COVID-19 subjects and healthy controls. Methods We used two publicly available gene expression datasets generated via RNA sequencing in two different samples; nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs). We performed a differential gene expression analysis between COVID-19 subjects and healthy controls in the two datasets and then functionally profiled their differentially expressed genes (DEGs). The genes involved in innate immunity were also determined. Results We found a clear difference in the host response to SARS-CoV-2 infection between the two sample groups. In COVID-19 subjects, the nasopharyngeal sample group indicated upregulation of genes involved in cytokine activity and interferon signalling pathway, as well as downregulation of genes involved in oxidative phosphorylation and viral transcription. Host response in COVID-19 subjects for the PBMC group, involved upregulation of genes involved in the complement system and immunoglobulin mediated immune response. CXCL13, GABRE, IFITM3 were upregulated and HSPA1B was downregulated in COVID-19 subjects in both sample groups. Conclusion Our results indicate the host response to SARS-CoV-2 is compartmentalized and suggests potential biomarkers of response to SARS-CoV-2 infection. Highlights Transcriptomic profiling from publicly available RNA-seq count data revealed a site-specific immune response in COVID-19. Host response was found cellular-mediated in nasopharyngeal samples and humoral-mediated in PBMCs samples. CXCL13, GABRE and IFITM3 commonly upregulated and HSPA1B downregulated in both sample groups highlights the potential of these molecules as markers of response to SARS-CoV-2 infection.

expression datasets generated via RNA sequencing in two different samples; nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs). We performed a differential gene expression analysis between COVID-19 subjects and healthy controls in the two datasets and then functionally profiled their differentially expressed genes (DEGs). The genes involved in innate immunity were also determined. Results: We found a clear difference in the host response to infection between the two sample groups. In COVID-19 subjects, the nasopharyngeal sample group indicated upregulation of genes involved in cytokine activity and interferon signalling pathway, as well as downregulation of genes involved in oxidative phosphorylation and viral transcription. Host response in COVID-19 subjects for the PBMC group, involved upregulation of genes involved in 

The ongoing global pandemic in 2020, is a viral outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with over 24 million confirmed cases that account for more than 820,000 confirmed deaths across the world (Pharmaceutical Technology, 2020). SARS-CoV-2 belongs to the coronavirus family (Coronaviridae) of viruses that cause mild or fatal respiratory tract infections in humans. The virus is contagious and infects humans by entering the cells through the attachment of its spike proteins to angiotensin-converting enzyme 2 (ACE2) receptors found on surface of the cell (Mathewson et al., 2008; Shereen et al., 2020; . The clinical manifestations of the disease caused by SARS-CoV-2, coronavirus disease 2019 include fever, dry cough, breathing difficulties (dyspnoea), headache and fatigue (Lima, 2020; CDC, 2019) . Other symptoms observed in some patients are sore throat in the prominent upper respiratory tract, sneezing, anosmia and rhinorrhoea , Hornuss et al., 2020 Lee et al., 2020; Lechien et al., 2020) .

Although there is an expression of interferon (IFN) in other coronavirus infections (Newton et al., 2016; Nelemans & Kikkert, 2019) , some studies on the immune response to viral infections in addition to the newly understanding of SARS-CoV-2, established that the virus suppresses various mechanisms in the interferon pathway thereby preventing the pattern recognition receptors (PRR), signalling and inhibiting host protein translation (Newton et al., 2016; Nelemans & Kikkert, 2019; Lei et al., 2020; Mantlo et al., 2020) . Previous studies also established that triggering of such exuberant inflammatory responses in the host leads to severe lung disease (Channappanavar et al., 2016) . Most COVID-19 patients with severe clinical presentation and poor prognosis exhibit dysregulated host immune response and enhanced levels of pro-inflammatory cytokines known as the "cytokine storm" . Recent studies done by Haung et al. (2020) and Xiong et al. (2020) also demonstrated elevated amounts of plasma IL2, IL6, IL7, IL10, GCSF, IP10, MCP1, MIP1A, and TNFα in severe cases of COVID-19 compared to mild cases, showing inflammatory cytokines release to be significantly associated with COVID-19 progression , Xiong et al., 2020 .

Transcriptome profiling allows the evaluation of gene expression changes in response to disease or treatment (Voineagu et al. 2011) . Transcriptome profiling of 8356 cells collected from COVID-19 patients and healthy controls revealed that COVID-19 patients exhibited abnormalities in their bronchoalveolar epithelial cells and that the SARS-CoV-2 virus suppresses gene expression in host cells (He et al., 2020) . However, the underlying molecular mechanisms of the inflammatory responses and pathogenesis of the COVID-19 in SARS-CoV-2 infection are not clearly understood.

Thus, analysing host transcriptional changes in response to SARS-CoV-2 infection is necessary to help describe the biological process underlying the pathogenesis of COVID-19.

In this study, we performed transcriptomic analysis of different samples sources from both COVID-19 patients and healthy controls ( Figure 1 ). We show that transcriptional response to SARS-CoV-2 infection in the two different compartments are distinct and reflect a local inflammation in nasopharyngeal site and circulating immune response in peripheral blood mononuclear cells (PBMC) samples in COVID-19 patients.

This is a secondary study from publicly available data. Gene expression data (RNA-Seq counts) of GSE152418 and GSE152075 datasets were downloaded from the NCBI Gene Expression Omnibus (GEO) database. The GSE152075 dataset was generated by RNA sequencing of nasopharyngeal swab samples from COVID-19 subjects and healthy controls (Randhawa et al., 2020; Lieberman et al., 2020) . The dataset was composed of 430 nasopharyngeal swab samples of COVID-19 subjects and 54 of healthy controls. The median age (years) of the COVID-19 patients enrolled in the study was 54 [2 -98] in which the majority was female (43%; unknown: 12%) (Lieberman et al., 2020) . The GSE152418 dataset was generated by RNA sequencing of PBMCs from COVID-19 subjects and healthy controls (Arunachalam et al., 2020) . The dataset was composed of 16 PBMC samples of COVID-19 subjects and of 17 healthy controls. The median age (years) of the COVID-19 patients was 56 [25 -94] with a majority of male (55%) (Arunachalam et al., 2020) .

SARS-CoV-2 infection was confirmed by RT-PCR in both studies. Nasopharyngeal samples were collected in the emergency departments on admission of the patients and PBMC samples during hospitalization.

DEGs analysis was performed on the control and disease samples in each nasopharyngeal and PBMC group using the DESeq2 package in R (Love et al., 2014) . Genes that fulfilled the criteria of an adjusted p-value < 0.05 and a threshold of log2 fold change > 1 were considered significant.

Ensembl IDs were converted to HUGO Gene Nomenclature Committee (HGNC) symbols using the g: Convert tool in g: Profiler (Raudvere et al., 2019). The common DEGs in both the nasopharyngeal and PBMC samples were identified. An ensemble of hierarchical and k-means clustering was then applied to these common DEGs to determine their discriminatory utility of the samples into their respective sample groups (i.e. Nasopharyngeal or PBMC). The DEGs were also searched for their involvement in innate immunity using the InnateDB database (Breuer et al., 2013 ).

Functional profiling of the upregulated and downregulated DEGs in the two sample groups were carried out using the g:GOSt tool in g: Profiler (Raudvere et al., 2019) with adjusted p-value < 0.05 set as cut off for significant terms.

The results were expressed in tables, graphs and illustrations when convenient. Heatmaps of the top 20 genes (10 up regulated and 10 down regulated) in both datasets were plotted using iDEP.91 server. The hkmeans and dendrogram plot functions were applied to a normalised data matrix of both nasopharyngeal and PBMC samples using software Orange Data Mining (Ljubljana University). Functional analysis was plotted using Prism (GraphPad software, Inc).

An overview of the gene expression in nasopharyngeal and PBMCs sample groups was observed in the principal component analysis (PCA), which suggests how significant the variation among the gene expression was between the two groups ( Figure 2 ). In nasopharyngeal samples, we observed a separation between healthy controls and COVID-19 subjects along the second principal component, although substantial overlap between groups remained (Figure 2 , A). A distinct cluster between healthy controls and cases was observed in the PBMC sample group (Figure 2 , B). Next, we performed a differential gene expression analysis relative to matched healthy controls, to explore host response to SARS-CoV-2 infection ( Figure 2 ). In the nasopharyngeal sample group, 745 genes were differentially expressed, of which 166 were upregulated, and 579 were downregulated (Figure 2 , C). In the PBMC sample group, 532 genes were differentially expressed, of which 524 were upregulated and 8 were downregulated (Figure 2 , D).

From the number of differentially expressed genes, we next sought to contrast and explore the quantitative changes between the sample groups relative to respective healthy controls. The top significant DEGs evidence a distinct expression pattern in the two sample groups (Figure 3 , Tables S1 and S2). Thirteen DEGs including CLU, CXCL13, GABRE, HSPA1B, IFITM3, IGHA2, IGHG1, IGHG3, ITGB5, MT1E, SELENBP1, TXNDC5 and UCHL1 were found to be commonly expressed between both sample groups. These genes encode for immunoglobulins, chemokines, ubiquitin, and proteins responsible for stress response and protein degradation. The genes CXCL13, GABRE and IFITM3, were upregulated in COVID-19 subjects in both sample groups. The genes CLU, IGHA2, IGHG1, IGHG3, ITGB5, MT1E, SELENBP1, TXNDC5 and UCHL1 were upregulated in COVID-19 subjects in the PBMC group but downregulated in COVID-19 subjects in the nasopharyngeal sample group. HSPA1B was downregulated in both sample groups. The expression pattern of these 13 commonly DEGs consistently discriminated nasopharyngeal and PBMC samples amongst the COVID-19 subjects by hierarchical clustering (Figure 3 , C).

To evaluate biological relevance, we enriched the interaction between the DEGs. Functional profiling of the nasopharyngeal upregulated DEGs identified significant terms such as chemokine activity, cytokine activity, inflammatory response, and type 1 interferon signalling pathway ( Figure   4 , A), indicating a cellular-mediated immune response. Functional profiling of the upregulated DEGs in COVID-19 subjects in the PBMC group identified significant terms such as immunoglobulin receptor binding, B cell-mediated immunity, complement activation, haemoglobin binding, oxygen carrier activity and cell division (Figure 4, B) . The transcriptional profile shown by PBMCs reflects a humoral and complement mediated response against SARS-CoV-2 infection. Ninety-two (92) of the DEGs in the nasopharyngeal group were found to be involved in innate immunity, of which 53 were upregulated, and 39 were downregulated.

Functional profiling of the downregulated DEGs in the nasopharyngeal sample identified significant terms such as RNA binding, oxidoreductase activity, cytochrome-c-oxidase activity, oxidative phosphorylation, viral transcription and selenocysteine synthesis (Table S5 ). There were only 8 downregulated genes in the PBMCs sample group and they were not functionally enriched.

Forty-three (43) 

This study was designed to analyse host transcriptional changes in response to COVID-19 from publicly available datasets, to contribute to the knowledge of the biological processes underlying the pathogenesis of COVID-19 and the immune responses elicited. Our results showed a distinct immune response in nasopharyngeal samples and PBMC samples in COVID-19 patients, as evidenced by the differential expression pattern. We have shown that apart from a compartmentalized and site-specific immune response, there was a set of genes commonly regulated in the two sample groups. These observations are in line with previous reports in which SARS-CoV-2 infection induces a highly inflammatory environment observed in nasopharyngeal samples and an innate immune response played by complement system in PBMCs (Blanco-Melo et al., 2020; Xiong et al., 2020) .

We showed that nasopharyngeal samples exhibited a regulation for local inflammation, compatible with the tropism of SARS-CoV-2 to nasal epithelial cells (Sungnak et al., 2020) . This response was shown to be specific at the infection site, that likely reflect in complementary and systemic elements of immune response in the periphery, as indicated in this study. The infection by SARS-CoV-2 is marked by a systemic inflammatory response that affects various organs in different manners (Gardinassi et al., 2020) . Although the elevated inflammatory response may be beneficial in fighting the infection, it may also lead to an over-production of pro-inflammatory cytokines that may cause damage to the olfactory epithelium, as well as adverse outcomes such as alveolar damage, respiratory failure and multiple organ dysfunction (Chen et al., 2017.; Huang et al., 2020; Xiong et al., 2020) . Cytokines have been shown to contribute to leukocyte recruitment via activating integrins, promoting migration of adherent leukocytes across endothelium and through the extracellular matrix (Butcher et al., 1996) . Therefore, cytokine and chemokine expression in the nasopharynx is possibly associated with the finding of upregulation of leukocytes migration.

Blanco-Melo and colleagues (2020), observed a strong chemokine expression in transcriptomic profile from nasopharyngeal swabs and low levels of IFN-I. In contrast to that, through the functional profiling in nasopharyngeal samples, we observed an activity regulated by Type I Interferon. In this study, the soluble levels of IFN-I were not addressed, but a possible counterbalance played by upregulation of anti-inflammatory signalling by IL-10 could be in line to what was observed by Blanco-Melo and colleagues (2020). Hachim et al. (2020) also reported that genes, especially the IFITM3 gene, involved in IFN response to a viral infection such as type 1 interferon signalling pathway, were upregulated in SARS-CoV-2 infected lung epithelial cells. This further elucidates the release of IFN by the innate immune system in response to viral RNAs, such as is the case with SARS-CoV-2 (Nelemans & Kikkert, 2019). Further investigation on the mechanism of recruitment and effector function of responding cells is required in order to better understand the process. The biological processes found in PBMCs are consistently directed towards a humoral-mediated response. Xiong and colleagues (2020) reported similar results from PBMCs, with the observation that genes upregulated in PBMCs of COVID-19 patients were enriched in complement activation, B cell-mediated immunity, and immunoglobulin-mediated humoral immune response. These results indicate a highly specific immune response in periphery. Indeed, Stahel and Barnum (2020) pointed out the importance of the complement system in the pathogenesis of COVID-19. Our results support the need for further studies to uncover the exact mechanism of the complement system in COVID-19.

A molecular signature is observed in the heatmap from PBMCs, albeit not so clearly in nasopharyngeal samples. The sample size, higher in nasopharyngeal sampling, may reflect heterogeneous observations from possible diverse clinical presentations. The fact we have found a specific cellular-mediated immune response in nasopharyngeal samples, even in a heterogeneous group of patients, reinforces the importance of the finding of commonly dysregulated genes with the PBMC sample group. Heat Shock Protein Family A (Hsp70) Member 1B -HSPA1B was downregulated in both sample groups. HSPA1B codes for a molecular chaperone that plays a vital role in cellular processes including protection of protein from stress and protein quality control system including correct folding of proteins (Kim & Oglesbee, 2012; Scieglinska et al ., 2019) . In addition, it has been found that viral infection stimulates HSPA1B the gene to increase its own replication (Kim & Oglesbee, 2012) . Therefore, during the viral infection of SARS-CoV-2, downregulation of HSP1AB might be an indirect immune response from the host to decrease the viral load by reducing the rate of translation of viral protein molecules. We highlight the need of further research to assess the effect of other RNA viruses on the expression of HSP1AB genes and whether the suppression of the gene benefits the host against the viral infection. Chemokine (C-X-C motif) ligand 13 -CXCL13 preferentially promotes migration of B lymphocytes into follicles.

Interferon Induced Transmembrane Protein 3 -IFITM3 is a protein-coding gene that disrupts the intracellular cholesterol homeostasis and inhibits the entry of viruses to the cell cytoplasm by hindering fusion of the virus with cholesterol depleted endosomes. IFITM3 is an interferon induced gene that aids in providing immunity against the viral infections (Feeley et al., 2011) . Together with downregulated HSP1AB and the upregulated genes CXCL13 and IFITM3, we draw attention to these molecules as potential biomarkers of disease progression. CXCL13 plays a vital role in the migration of B cells during viral infection (Phares et al., 2016) and IFITM3 is also involved in antiviral response (Zhang et al., 2020) . This may be due to association with the activation of the cytokine storm in infected patients during immune response (Gao et al., 2020; Huang et al., 2020; Ruan et al., 2020) . Nevertheless, Hachim et al. (2020) also reported an early upregulation of IFITM3 in SARS-CoV-2 infected patients. Taken together, the roles in the infection played by these commonly expressed genes at a critical site -possibly the entry route of viral-host interaction in the nasopharynx raises the possibility of low invasive tests to investigate these genes in peripheral blood and support personalized medicine.

Here, we provided insights on the potential use of transcriptomic data to address site-specific differential gene expression in response to SARS-CoV-2. Our results direct the potential of markers to discriminate sample source and differential host response to SARS-CoV-2 and possibly other viral infections. Altogether, we suggest further investigation of whether the gene products can be used as potential biomarkers as a COVID-19 screening process.

Using transcriptomic analysis, we identified differentially expressed genes between COVID-19 subjects in nasopharyngeal and PBMC sample groups in comparison to healthy controls. We also illustrated the prominent immune response genes involved in SARS-CoV-2 infection in both sample types. The differential expression profile observed between the sample groups suggests the existence of different markers of the infection and which may possibly have diagnostic and/or prognostic utility in COVID-19. However, further studies are required to fully characterise the genes involved in the SARS-CoV-2 infection.

The first three authors have contributed equally. Mathewson, A. C., Bishop, A., Yao, Y., Kemp, F., Ren, J., Chen, H., Xu, X., Berkhout, B., van der Hoek, L. 

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Imbalanced host response to SARS-CoV-2 drives development of COVID-19

InnateDB: systems biology of innate immunity and beyond-recent updates and continuing curation

Lymphocyte homing and homeostasis

Novel Coronavirus Wuhan , China: Symptoms. CDC

Acute inflammation regulates neuroregeneration through the NF-κB pathway in olfactory epithelium

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry

Diagnostic utility of clinical laboratory data determinations for patients with severe COVID-19

Immune and metabolic signatures of COVID-19 revealed by transcriptomics data reuse

iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data

Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells

Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients

Anosmia in COVID-19 patients

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Virus-heat shock protein interaction and a novel axis for innate antiviral immunity

Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19

Washington LC dos-Santos (MD, PhD) for his consultancy in this study. Sarah H Carl, Ph.D., was a mentor for this project.

The authors have declared there are no conflicts of interest involved in this research.

Note: Shown are gene symbols, gene names, fold change (log2FC), p-adjusted value and gene expression status. (1) Gene expression data (RNA-Seq counts) of GSE152418 and GSE152075 datasets were downloaded from the NCBI Gene Expression Omnibus (GEO) database.(2) Differentially expressed gene (DEG) analysis was performed on the control and disease sample groups in each nasopharyngeal and PBMC group using the DESeq2 package in R. Genes that fulfilled the criteria of an adjusted p-value < 0.05 and a threshold of log2 fold change > 1 were considered significant.(3) Ensembl IDs of DEGs were converted to HUGO Gene Nomenclature Committee (HGNC) symbols using the g: Convert tool in g: Profiler. (4) An ensemble of hierarchical and k-means clustering was then applied to common DEGs in both the nasopharyngeal and PBMC sample groups and DEGs were also searched for their involvement in innate immunity using the InnateDB database. (5) Functional profiling of DEGs in the two sample groups were carried out using the g:GOSt tool in g: Profiler with adjusted p-value < 0.05 set as cut off for significant terms. (6) Associated gene ontology (GO), molecular function (MF), biological process (BP), KEGG pathway, Reactome pathway, and WikiPathway was identified for each dataset. for both nasopharyngeal and PBMC samples, downregulation of CLU,  IGHA2, IGHG1, IGHG3, ITGB5, MT1E, SELENBP1, TXNDC5 and UCHL1 in nasopharyngeal sample and upregulation in PBMC sample. The nasopharyngeal sample revealed an inflammatory response cellular mediated against SARS-CoV-2 infection. Viral protein interaction between cytokine and cytokine receptor occurs (1) in antigen-presenting cells, producing cytokines/chemokines (2) and creating a signalling gradient to favour leukocyte migration (3) to the site of infection. PBMCs sample displayed a humoral response, played by circulating immunoglobulin production mediated by B cells (4) that promote antigen binding, activating the classical pathway of complement system cascade (5). Creation of C4 and C2 activators occurs (6) and cleavages into C2a and C4b (7) to initiate C3 and so on to complete the activation of the complement cascade.